Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

VictoryShares® Expands Suite of Thematic ETFs
VictoryShares® Expands Suite of Thematic ETFs


Victory Capital Holdings, Inc. (NASDAQ: VCTR) (“Victory Capital” or the “Company”) today announced that it has launched the VictoryShares Top Veteran Employers ETF (VTRN) and the VictoryShares

COVID-19 Raises Anxiety Levels for College Students by Presenting Extraordinary Health and Financial Challenges
COVID-19 Raises Anxiety Levels for College Students by Presenting Extraordinary Health and Financial Challenges


AIG Retirement Services, a leading retirement plan provider for tax-exempt and public sector employers including education institutions, and EVERFI, the nation’s leading social impact education

Havn Life Announces Launch of a Range of Natural Health Products
Havn Life Announces Launch of a Range of Natural Health Products

The 7 initial formulations are designed to support and enhance memory and brain function, the immune system, energy levels, and overall wellness, while reducing the negative impacts of

Novocure Receives CE Mark for NovoTTF-100L™ System
Novocure Receives CE Mark for NovoTTF-100L™ System


Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, today announced that it has received the CE Mark for the NovoTTF-100L

Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Deciphera Presents Updated Preliminary Data from DCC-3014, its CSF1R Inhibitor Program, in Tenosynovial Giant Cell Tumor Patients at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting


Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced the presentation of encouraging preliminary results from the ongoing Phase 1/2 study of DCC-3014, a highly selective, oral

CI Financial Enters 12th U.S. RIA Transaction of 2020; Agreement to Acquire US$2.7-Billion Roosevelt Investments Brings Total Projected U.S. Wealth Assets to Approximately US$16.5 Billion
CI Financial Enters 12th U.S. RIA Transaction of 2020; Agreement to Acquire US$2.7-Billion Roosevelt Investments Brings Total Projected U.S. Wealth Assets to Approximately US$16.5 Billion


CI Financial Corp. (“CI”) (TSX: CIX) and The Roosevelt Investment Group, Inc. (“Roosevelt”) today announced an agreement under which CI will acquire 100% of Roosevelt, a New York-based registered

Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting
Deciphera Presents Data from QINLOCK® (Ripretinib) Program at the Connective Tissue Oncology Society (CTOS) 2020 Virtual Annual Meeting


Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), today announced data presentations from clinical studies of QINLOCK, the Company’s switch-control tyrosine kinase inhibitor approved in the U.S. for

More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research
More Than 75 Companies Adopt Veeva Vault CTMS to Accelerate Clinical Research


As the need to improve efficiency and speed in trials grows, more than 75 organizations, including six of the top 20 pharmaceutical companies, are unifying clinical information and processes with

Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens
Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens


Pfizer Inc. (NYSE: PFE) announced today positive top-line results from the Phase 3 JADE REGIMEN study. This 52-week study investigated abrocitinib, an investigational oral once-daily Janus kinase 1

Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2


Pfizer (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that they have reached an agreement with the European Commission to supply 200 million doses of their investigational BNT162b2

ICON Releases First Environmental, Social and Governance Report
ICON Releases First Environmental, Social and Governance Report


ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health

NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)
NanoString Highlights Growing Body of Spatial Biology Research Presented at the 35th Annual Meeting of the Society of Immunotherapy of Cancer Conference (SITC)


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the highlights of more than 35 NanoString-related

Amex Reports Phase Two Metallurgical Results from Three Composite Samples from the HGZ at Perron – Confirms Gold Recovery of +99% - and Grants Stock Options
Amex Reports Phase Two Metallurgical Results from Three Composite Samples from the HGZ at Perron – Confirms Gold Recovery of +99% - and Grants Stock Options

MONTREAL, CANADA – November 11, 2020 - Amex Exploration Inc. (“Amex or the Company”) (TSX-V: AMX, FRA: MX0, OTCQX: AMXEF) is very pleased to report additional metallurgical results from the

BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine
BioVaxys Announces 96.4 Percent Positive Antibody Immune Response Results from an In Vivo Murine Model Study of Its SARS-CoV-2 Vaccine

Vancouver, British Columbia, November 11, 2020 —  BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB) (“BioVaxys”) is pleased to announce that results from its preclinical animal study (also known

Makara Provides Corporate Update
Makara Provides Corporate Update

Vancouver, Canada, November 11, 2020 - Makara Mining Corp. (CSE: MAKA; FSE: MK0; OTC: MAKAF) (“Makara” or the “Company”) is pleased to provide the following corporate update on its three

Spodumene Concentrator Pilot Testwork Launched
Spodumene Concentrator Pilot Testwork Launched

-          Pilot testwork will be completed on a 50t sample of ore collected from Piedmont’s Core Property

-          SGS Canada will complete dense medium and flotation pilot work over the

Technical Outlook of General Motors Company (GM)
Technical Outlook of General Motors Company (GM)
There is a bullish trend for General Motors with positive momentum. Our research team suggests a buy signal for GM. For a daily investment approach, the summary indicates a strong buy signal
Mountain Valley MD Confirms Major Breakthrough in Solubalizing Ivermectin, Files Patent to Protect Intellectual Property and its Application to Covid-19 Therapy
Mountain Valley MD Confirms Major Breakthrough in Solubalizing Ivermectin, Files Patent to Protect Intellectual Property and its Application to Covid-19 Therapy

VANCOUVER, B.C. – November 11, 2020 - Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) is pleased to announce that it has confirmed a breakthrough in achievin

Treasury Metals Inc. Announces CEO Appointment
Treasury Metals Inc. Announces CEO Appointment

 

TORONTO, November 11, 2020 – Treasury Metals Inc. (TSX: TML) (“Treasury” or the “Company - https://www.commodity-tv.com/ondemand/companies/profil/treasury-metals-inc/) is pleased to

Voyager Digital wins The People's Choice Award at the 6th annual 2020 Benzinga Global FinTech Awards
Voyager Digital wins The People's Choice Award at the 6th annual 2020 Benzinga Global FinTech Awards

- Company Also Scheduled to Present at The Benchmark Company’s 9th Annual Discovery

One-on-One Virtual Investor Conference on November 18, 2020 -

 

NEW YORK, November 11, 2020 - Voyager

Halo Labs Closes Acquisition of United Kingdom Cannabis Distributor Canmart
Halo Labs Closes Acquisition of United Kingdom Cannabis Distributor Canmart

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated September 16, 2020 to its short form base shelf prospectus dated

Skeena Resources Announces Overnight Marketed Public Offering
Skeena Resources Announces Overnight Marketed Public Offering
Skeena Resources Limited

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE

Crowd Media Launches “Talking Head” Beta and Signs Two Strategic Partnerships
Crowd Media Launches “Talking Head” Beta and Signs Two Strategic Partnerships

11th November 2020

 

Highlights:

 

-          Launched a beta version of its conversational commercetalking head” 12 months ahead of schedule

-          Crowd’s “talking head” has